Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Comparing TIL to Standard Ipilimumab in Patients With Metastatic Melanoma (TIL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02278887
Recruitment Status : Recruiting
First Posted : October 30, 2014
Last Update Posted : January 12, 2018
Sponsor:
Collaborators:
Copenhagen University Hospital at Herlev
University of Manchester
Information provided by (Responsible Party):
The Netherlands Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2019
Estimated Study Completion Date : September 2020